. William C. Campbell is an American biologist and parasitologist, who got a job in the research laboratory of Merck, Sharp and Dohme, the pharmaceutical firm. He discovered that a component from one of Omura's Streptomyces cultures was very effective in killing off parasites in domestic animals. The bioactive agent was purified and named avermectin. Avermectin was subsequently chemically modified to ivermectin, which turned out to be highly effective in both animals and humans against a variety of parasites. Ivermectin was marketed as a drug for veterinary use in the early 1980s by pharmaceutical giant Merck and was extraordinarily profitable. In 1978 Campbell had suggested to his boss that, in addition to its success in veterinary medicine, the drug might also be effective in treating river blindness in humans. He and his colleagues persuaded Merck to continue research and, when that proved successful, to provide the drug for free, since the potential patients certainly could not afford to pay for it 1, 5, 7, 8 . Professor Satoshi Õmura is a Japanese microbiologist widely recognized as a world expert in the field of bioorganic chemistry, particularly for the discovery, development, biosynthesis and manipulation of useful chemicals derived from naturally-occurring microorganisms. He is an expert in isolating natural products, focused on a group of bacteria, Streptomyces which live in the soil known to produce a plethora of agents with antibacterial activities. From many thousand different cultures, he selected about 50 of the most promising, and one of these cultures later turned out to be Streptomyces avermitilis, the source of avermectin. The ivermectin, a dihydro derivative of avermectin was discovered and developed by collaborative research of Õmura and Merck Company as a macrolide anthelmintic antibiotic. It is widely held that the discovery and use of ivermectin represents the greatest public health intervention of the last quarter of the 20th century and can be regarded as on a par with the discovery and use of penicillin 4, 7, 8 . The eradication programs for river blindness and lymphatic filariasis, currently being orchestrated by the WHO, are based primarily on the use of ivermectin. Ivermectin has been donated by the Merck Company and the Kitasato Institute since 1987, and the drug is being administered to around 300 million people annually. It is envisaged that river blindness will be eliminated globally by 2025 and lymphatic filariasis by 2020 8 . Professor Youyou Tu is a Chinese medical scientist, pharmaceutical chemist, and educator. She is the first Chinese Nobel laureate in physiology or medicine, and the first Chinese citizen to receive the Nobel Prize in natural sciences. She was born, educated and carried out research exclusively in China. 1 Youyou Tu is best known for discovering artemisinin (also known as qinghaosu) and dihydroartemisinin, used to treat malaria, which saved millions of lives. Her discovery of artemisinin and its treatment of malaria are regarded as a significant advance of tropical medicine in the 20th century and health improvement for people from developing countries in South Asia, Africa, and South America 6, 9, 10 . Malaria was traditionally treated by chloroquine or quinine, but with declining success. By the late 1960s, efforts to had the responsibility" she said. Artemisinin represents a new class of antimalarial agents that rapidly kill the malaria parasites at an early stage of their development, which explains its unprecedented potency in the treatment of severe malaria. When used in combination therapy, it is estimated to reduce mortality from malaria by more than 20% overall and by more than 30% in children. For Africa alone, this means that more than 100 000 lives are saved each year 6, 9, 10 . R E F E R E N C E S
